Orbit Genomics logo — The Future of Precision Healthcare

Orbit Genomics

The Future of Precision Healthcare

Founded 2003 United States Boulder, United States 8 employees Unknown

General Information

Company Name Orbit Genomics
Founded Year 2003
Location United States Boulder, United States +1
Employees 8
Funding Stage Unknown
Social

Get notified when Orbit Genomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Orbit Genomics

Orbit Genomics, founded in 2003, is creating waves in the field of precision healthcare with its theme of ushering in "The Future of Precision Healthcare." This innovative company is based in the United States, focusing on the diagnosis, treatment, and prevention of complex diseases such as cancer, heart disease, and neurological disorders.

The cornerstone of Orbit Genomics's technological innovation is its patented, AI-powered OrbiSeq™ platform. This advanced technology analyzes previously inaccessible genetic variations crucial for disease diagnosis, risk stratification, and intervention strategies. Their leading product, a blood test for early-stage lung cancer diagnosis, is a testament to the company's groundbreaking approach.

Orbit Genomics recently secured a Non Equity Assistance investment from the CancerX Startup Accelerator on February 26, 2024. This support aligns with their ambitious vision in transforming healthcare solutions.

Taxonomy: Precision Healthcare, Genomics, AI-Enabled Platform, OrbiSeq™ Technology, Genetic Variation Analysis, Disease Diagnosis, Risk Stratification, Disease Prevention, Early Disease Detection, Repetitive DNA Analysis, Inherited and Acquired Disease Risk, Lung Cancer Diagnosis, Neurological Diseases, Complex Disease Treatment, Cardiovascular Diseases

Services & Products

Non-invasive diagnostic tests
AI-powered genomics analysis
Early-stage cancer diagnosis
Product development pipeline across cancer, cardiovascular and neurological diseases

Target Customers

Healthcare providers Patients with indeterminate pulmonary nodules Biotechnology and pharmaceutical companies Clinical laboratories

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Unknown •••••• 1 •••• •••• 01 Feb 2024
Seed •••••• 1
Investor
01 Aug 2022
Seed •••••• - 01 Jun 2019

Orbit Genomics Alternatives & Competitors

View All Alternatives
Orbit Genomics vs

Diagnostics for diverse diseases at the point-of-care, while you wait.

Orbit Genomics vs

Future of Healthcare, Healthcare of Future

5 employees
AI, Biotechnology
Orbit Genomics vs
Dia4Me
Dia4Me Turkey

Diagnostic for metabolism

2 employees

FAQ About Orbit Genomics

The Future of Precision Healthcare
Orbit Genomics was founded in 2003.
Orbit Genomics is headquartered in Boulder, United States.
Orbit Genomics has approximately 8 employees.
Orbit Genomics has completed 3 funding rounds. The latest funding stage is Unknown.
Orbit Genomics offers: Non-invasive diagnostic tests, AI-powered genomics analysis, Early-stage cancer diagnosis, Product development pipeline across cancer, cardiovascular and neurological diseases.
Top alternatives and competitors to Orbit Genomics include Dandelion Diagnostics, Orbuculum Genolytics Pvt Ltd, Dia4Me, RespiQ, Hummingbird Diagnostics GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orbit Genomics and Dandelion Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Orbit Genomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy